| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |